Expertise: Oncology & Hematology 93 results

Oncology & Hematology

Harnessing Innovation in Oncology: Insights from ASCO 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting offered a compelling look into the future of cancer care—one that is increasingly shaped by innovation, data, and a deeper commitment to the patient experience. From artificial intelligence (AI) transforming...

Clinical Development

Bringing an Oncology Asset to Market: In-House vs Outsource?

During the multifaceted journey of bringing a promising therapeutic to market, sponsors are faced with a critical choice—whether to manage asset development in-house or to outsource to a clinical research organization (CRO) partner. This decision can influence timelines, costs, control...

Oncology & Hematology

What is Logic-Gating and Why Does It Matter in CAR-T Therapy? 

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for certain hematological malignancies, offering hope where conventional therapies have been exhausted. By reprogramming a patient's own T-cells to recognize and attack cancer cells, CAR-T therapy embodies the promise...